Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer

NCT02448173 is registered in ClinicalTrials.gov with Vaccinogen Inc as lead sponsor.

NCT NCT02448173
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02448173 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer
Lead sponsor
Vaccinogen Inc
Phase
Phase 3
Overall status
Not yet recruiting
Start date
August 31, 2026
Completion date
August 31, 2033
Enrollment
550 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage ii colon cancer